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Abstract
Background: In Mongolia, adequate early diagnosis and treatment of developmental hip dysplasia (DDH) have been
unavailable and its incidence was unknown. We determined the incidence of ultrasonographic DDH in newborns and
established adequate procedures for diagnosis and treatment of DDH at the largest maternity hospital in
Ulaanbaatar, Mongolia.
Methodology/Principal Findings: During one year (Sept 2010 – Aug 2011) we assessed the hips newborns using
ultrasound and Graf’s classification of DDH. 8,356 newborns were screened; median age at screening was 1 day.
We identified 14,873 Type 1 (89.0%), 1715 Type 2a (10.3%), 36 Type 2c (0.2%), 70 Type D (0.4%), 14 Type 3
(0.08%), and 4 Type 4 hips (0.02%). Children with Type 1 hips (normal) were discharged. Children with Type 2a hips
(physiologically immature) received follow-up ultrasounds at monthly intervals. Children with Type 2c to 4 (DDH;
deformed or misaligned hip joint) hips were treated with a Tubingen hip flexion splint and also followed up. The hip
abnormalities resolved to mature hips in all children who were followed up. There was no evidence for severe
treatment related complications.
Conclusion/Significance: This study suggests that the incidence of DDH in Mongolian neonates is comparable to
that in neonates in Europe. Early ultrasound-based assessment and splinting treatment of DDH led to mature hips in
all children followed up. Procedures are feasible and will be continued.
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Introduction
In Mongolia, adequate early diagnosis and treatment of
developmental hip dysplasia (DDH), a frequent developmental
deformation or misalignment of the hip joint [1], is currently not
available. DDH can be cured with simple measures if adequate
methods for diagnosis and treatment are available. However, in
Mongolia diagnosis of DDH is currently based on clinical signs
and symptoms followed up with x-ray of the hips. X-ray
equipment is often outdated leading to high exposure to
radiation. Diagnosis is currently usually made late, i.e. at 6
months of age. Treatment in Mongolia is based on overhead
extensions for repositioning, and Pavlik harnesses with a
forced abduction of up to 90 degrees, which can cause
avascular necrosis of the femoral head. Thus, alternative
methods for DDH screening need to be tested to reduce
avoidably morbidity from DDH.
In Europe, incidence rates of hip abnormalities in unselected
newborn populations indicate physiologically immature hips in
3% to 13% and deformed or misaligned hips in 1-3% of
children [2-4]. The incidence of DDH in Mongolia has not been
established yet.
We aimed to 1) determine the incidence of ultrasonographic
detected hip abnormalities in an unselected newborn
population and 2) to test the feasibility of ultrasonographic
screening for DDH at the largest maternity hospital in
Ulaanbaatar/Mongolia.
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Methods
Ethics statement
We received ethical approval from the Mongolian ethical
review committee, commissioned by the Ministry of Health. All
parents signed a consent form. All data were anonymized
before analysis.
Sample/Procedure
In a prospective birth cohort study we evaluated the hips of
all newborns at National Center for Maternal and Child Health
(NCMCH), the largest maternity hospital in Mongolia, with
ultrasound between September 1, 2010 and August 31, 2011.
We did the baseline assessment within two days after birth,
before families left the hospital. We classified hip morphology
and stability according to Graf: Type 1 hips were mature; Type
2a hips were physiologically immature; Type 2c hips were
dysplastic but still centered; Type D hips were dyplastic and
decentered (first stage of luxation); Type 3 were luxated; and,
Type 4 hips were luxated with trapped cartilage. Types 2c to 4
were summarized as DDH [5]. Hips were not classified as Type
2b, because the children in our cohort were younger than 12
weeks and the Type 2b diagnosis is restricted to children aged
older than 12 weeks.
After baseline assessment the procedure followed SVUPP
recommendations. Children with Type 1 hips were discharged
without any further need of treatment or follow-up care.
Children with Type 2a hips at baseline were followed up by
ultrasound in monthly intervals at NCMCH until they matured.
Children who had 2a hips during the course of follow-up were
either followed up (Type 2a+), or treated if the hip insufficiently
matured (Type 2a-). Children with Type 2c to 4 hips were
treated with a Tubingen hip flexion splint and also followed up
until fully matured. The splint was worn 24 hours per day and
parents received instructions on how to fix and remove it. The
Tubingen splints were reusable, easy to use, and made of a
hygienic, plastic material. Children with Type 4 hips that could
not be splinted were referred to the National Center for
Traumatology and Orthopedics.
The screening program was done within hospital-based a
Swiss-Mongolian collaboration project. In Switzerland, the
Swiss Association for Pediatric Ultrasound (SVUPP) subsidized
a group of physicians responsible for creating the project
framework and securing funding (Swiss-Mongolian hip
dysplasia project; SMOPP). Members of SMOPP trained
physicians at the NCMCH to apply standardized ultrasound
methods for the screening of newborns’ hips. The screening
equipment consisted of a ultrasound device operating with a
7-10 MHz linear array transducer. It included a Sonofirst
holding crade and transducer fixation unit (Orthopunkt,
Solothurn), to prevent tilting errors. A frame grabber (Campus
medicus, Klughammer GmbH, Deggendorf) captured each
sonogram from the device. The frames were saved in a secure
database and transmitted to experts from SMOPP in
Switzerland who checked the diagnostic accuracy and
management within 48 hours. Discrepancies between
Mongolian and Swiss diagnoses were resolved by discussion
and consensus.
We collected information on variables known to be
associated with DDH in other populations [6]: female gender,
breech birth, multiple births, birth weight > 4,500 g, and family
history of DDH (parents or siblings).
We performed descriptive analyses and Student’s t-tests with
Stata 12.0 (Stata Corporation, Austin, Texas). In the main
analysis, we used the child and not the hip as unit of analysis.
If a child had hips with different morphologies, we evaluated
the child based on the worst hip. In a sensitivity analysis, we
used the hip as unit of analysis for initial Type 2a hips.
Results
Of the 8,389 children born between September 1, 2010 and
August 31, 2011, 33 were excluded because of congenital
malformations, e.g., myelomeningocele and club feet. None of
the parents declined participation in the study and 8,356
children were included. Characteristics of participants are
summarized in Table 1. A mean of 23 children were born at
NCMCH per day. Their median age at ultrasound examination
was 1 day (interquartile range: 0-2 days). Ninety-eight percent
were born at term. Forty-nine percent were female, and 1-2%
of children had other risk factors including breech births,
multiple births, birth weight > 4,500 g, or had a parent or sibling
with DDH.
Incidence of hip types at baseline examination is shown in
Table 2. We found 14,873 mature hips (89.0%), 1,715
physiologically immature hips (10.3%), 36 dysplastic, centered
hips (0.2%), 70 dysplastic, decentered hips (0.4%), 14 luxated
hips (0.08%), and 4 luxated hips with trapped cartilage
(0.02%). 7,110 children (85.1%) had two mature hips. 1,146
newborns (13.7%) had one or two physiologically immature
hips. One hundred newborns (1.2%) had one or two DDH hips:
76 had one DDH hip; 24 had two DDH hips.
Table 1. Characteristics of participants.
  N %
Number of children born per day mean +/- SD 23 +/- 7  
 median 23  
 interquartile range 18-27  
 range 1-51  
Age at ultrasound examination
(days) mean +/- SD 1.9 +/- 4.9  
 median 1  
 interquartile range 0-2  
 range 0-96  
Gestational Age Term 8205 98.2
 Preterm 151 1.8
Risk factors Female 4089 48.9
 Breech birth 165 2.0
 Multiple 92 1.1
 Weight at birth ≥ 4500g 136 1.6
 Parent or sibling with DDH 119 1.4
Abbreviations: SD, standard deviation; DDH, developmental dysplasia of the hip.
doi: 10.1371/journal.pone.0079427.t001
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Risk factors associated with DDH are shown in Table 3.
Newborns who had a parent or sibling with DDH presented 12
times more often with a DDH hip compared to newborns whose
parents and siblings had no DDH (Table 3). The risk was
increased 4.8-fold in those born in a breech position, compared
to those who were not. The risk was also increased 4.8-fold in
females and 2.5-fold in those with a birth weight above 4,500 g.
There was no difference in risk when multiple births were
compared with single births.
All newborns with two Type 1 hips were discharged without
further need of treatment or follow-up care. The 1,137
newborns (99.2%) with one or two Type 2a hips and no worse
hip were followed up with ultrasound at monthly intervals; in
nine children (0.8%), the procedure that was actually carried
Table 2. Incidence of hip types at baseline.
Type Any hipa Worse hipb
 % (n) % (n)
1 89.0 (14873) 85.1 (7110)
2a 10.3 (1715) 13.7 (1146)
2c 0.2 (36) 0.4 (30)
D 0.4 (70) 0.7 (56)
3 0.08 (14) 0.1 (12)
4 0.02 (4) 0.02 (2)
Total 100 (16712) 100 (8356)
a Number of hips
b Number of children; if a child had hips with different morphologies, the worse hip
counted
doi: 10.1371/journal.pone.0079427.t002
Table 3. Incidence and incidence risk ratio for type 2c to 4
hips according to risk factors present vs. not present at
screening.
 Any hip was type 2c to 4a Worse hip was type 2c to 4b
 Incidence  
Incidence risk
ratio   Incidence  
Incidence risk
ratio
 % (n) (95% CI) % (n) (95% CI)
Overall 0.7 (124) - 1.2 (100) -
If any risk factor
from below
present
1.3 (110) 7.3 (4.2-12.7) 2.0 (87) %1.1 (3.5-11.1)
- parent or sibling
with DDH 7.6 (18) 11.8 (7.3-19.1) 12.6 (15) %1.1 (7.3-20.5)
- breech birth 3.3 (11) 4.8 (2.6-8.9) 4.8 (8) %1.1 (2.1-8.7)
- female 1.2 (102) 4.8 (3.1-7.7) 2.0 (80) %1.1 (2.6-6.8)
- birth weight ≥
4500g 1.8 (5) 2.5 (1.0-6.2) 3.0 (4) %1.1 (0.9-6.7)
- multiple 0.5 (1) 0.7 (0.1-5.2) 1.1 (1) 0.9 (0.1-6.4)
a Number of hips
b Number of children; if a child had hips with different morphologies, the worse hip
counted
Abbreviations: CI, confidence interval; DDH, developmental dysplasia of the hip.
doi: 10.1371/journal.pone.0079427.t003
out did not conform to SVUPP rules: One child was discharged,
eight children were treated. 99 newborns (98%) with 2c-4 hips
were treated with a Tubingen hip flexion splint; one child (1%)
was discharged which was not conform with SVUPP rules.
Development of the hips over the course of follow-up is
visualized in Figures 1-4 and Figures S1-S2. Of the 1146
children (68.2%) with one or two Type 2a hips and no worse
hip at baseline, 781 attended a first follow-up visit (Figure 1);
364 were lost to follow-up. Six hundred and seven of 781
(77.7%) had developed Type 1 hips; 149 (19.1%) still had Type
2a hips; and 25 (3.2%) had Type 2c-3 hips (fulfilling DDH
criteria). Consequently, children with 2a hips that had
insufficiently matured and all children with 2c-3 hips received
follow-up treatment at first. Of the 174 children (84.5%) with
type 2a-3 hips at first follow-up, 147 attended a second follow-
up visit; 26 were lost to follow-up. One hundred and twenty-one
of 147 (82.3%) had developed mature hips; 26 (17.7%) had
physiologically immature hips. Of the 23 (91.3%) children who
consecutively attended a third follow-up visit, 21 had mature
hips. The two children with persistent 2a hips had mature hips
within one further follow-up visit. In Figure 2, we show
development over the course of follow-up according to single
2a hips as unit of analysis at baseline. Here, those 2a hips
combined with worse hips also appear. This results in an
increased number of observations and a higher proportion of
treated 2a hips, however, the overall result is similar to above.
Of 30 children (93.3%) with one or two type 2c hips and no
worse hip at baseline, 28 attended a first follow-up visit (Figure
3); two were lost to follow-up. Eighteen of 28 (64.3%) had
developed mature hips, and 10 (35.7%) had physiologically
immature hips. Nine of ten children (90%) with type 2a hips at
first follow-up attended a second follow-up visit; one was lost to
follow-up. Seven of nine (77.8%) had developed mature hips; 2
(22.2%) still had physiologically immature hips. One of two
(50%) had matured hips at a third follow-up visit. All of these
children received treatment.
Of the 56 children (89.3%) with one or two Type D hips and
no worse hip at baseline, 50 attended a first follow-up visit
(Figure 4); six were lost to follow-up. Thirty of 50 (60%) had
developed mature hips, 19 (38%) had physiologically immature
hips, and 1 child (2%) still had a type D hip. Within a second
and third follow-up visit, all children developed mature hips. All
of these children received treatment.
Ten of the 12 children (83.3%) with one or two Type 3 hips
and no worse hip at baseline attended a first follow-up visit
(Figure S1); two were lost to follow-up. Two of ten (20%) had
developed mature hips; eight (80%) had physiologically
immature hips. Five of eight children (62.5%) with Type 2a hips
at first follow-up attended a second follow-up visit; three were
lost to follow-up. Four of five (80%) had developed mature hips;
one (20%) still had physiologically immature hips. All of these
children received treatment. We cannot report the result of the
planned procedure in those two patients with one or two Type 4
hips at baseline (Figure S2). The family of one child declined
treatment and asked for discharge, despite detailed
information. In the second child, trapped cartilage made a
reposition by Tubingen splint impossible. However, the local
orthopedists were not able to offer a different treatment
Developmental Dysplasia in Mongolia
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Figure 1.  Development of type 2a hips on person levela.  a If a child had hips with different morphologies, the worse hip counted
(N=number of children); b Numbers in brackets: (X/Y) X=control, Y=treat. Abbreviation: FU, Follow-up visit; c 4th FU not visualized (2
children with type 1 hips).
doi: 10.1371/journal.pone.0079427.g001
Figure 2.  Development of type 2a hips on hip levela.  a Any hip (N=number of hips); b Numbers in brackets: (X/Y) X=control,
Y=treat. Abbreviation: FU, Follow-up visit; c 4th FU not visualized (3 children with type 1 hips).
doi: 10.1371/journal.pone.0079427.g002
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Figure 3.  Development of type 2c hips on person levela.  a If a child had hips with different morphologies, the worse hip counted
(N=number of children); b Numbers in brackets: (X/Y) X=control, Y=treat. Abbreviation: FU, Follow-up visit; c 4th FU not visualized (1
child with type 1 hips).
doi: 10.1371/journal.pone.0079427.g003
Figure 4.  Development of type D hips on person levela.  a If a child had hips with different morphologies, the worse hip counted
(N=number of children); b Numbers in brackets: (X/Y) X=control, Y=treat. Abbreviation: FU, Follow-up visit.
doi: 10.1371/journal.pone.0079427.g004
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strategy before 7 months of age, so that the child was
transferred to Switzerland and operated on both hips, followed
by cast and later splint fixation. The treatment seems to be
successful, though is not yet finished.
Overall, 188 of 8356 (2.2%) children received treatment
(Table 4). 107 (1.3%) initiated treatment after baseline
assessment, and 81 (0.9%) initiated treatment during follow-up.
A small proportion of children who were assigned to receive
treatment had to continue treatment after follow-up visit 1
(n=40), visit 2 (n=6), and visit 3 (n=3).
The median time interval between baseline and the first,
second and third follow-up visit was 33, 64 and 95 days,
respectively (Table 5). The mean was higher for all three
intervals compared to the median time interval, documenting a
skewed distribution. The mean time interval was a bit smaller in
2c-4 hips compared with 2a hips, and in bilateral compared to
unilateral 2c-4 hips, without being statistically significant (37 vs.
42 days, p=0.13; 33 vs. 38 days, p=0.23; respectively). There
was no evidence for severe treatment related complications.
Discussion
We found an incidence of ultrasonographically detected DDH
of 0.7% in Mongolian newborns including 0.2% Type 2c, 0.4%
Type D, 0.08% Type 3 and 0.02% Type 4 hips. In all children
who were treated with a Tubingen hip flexion splint within the
first few weeks of life, hip abnormalities resolved to Type 1.
There was no evidence for severe treatment related
complications.
This is the first study on the incidence of DDH in newborns in
Mongolia. Our results are based on a large birth cohort
comprising approximately 14% of newborns in Mongolia
(8389/57020 newborns during one year) [7,8]. Mongolia has a
centralized health care system and despite the size of the
country; most women (44%) from across the country give birth
in a hospital in Ulaanbaatar like NCMCH [9]. It is also the first
screening in Asia on DDH in newborns using Graf’s method.
Our study proofs the feasibility of ultrasound based screening
in Mongolia. Physicians in Mongolia were trained to use and
interpret sonograms following standardized procedures. With
Table 4. Decision on procedure at baseline and follow-up
visits.
Time point Discharge Control Treatment Total





 % (n) % (n) % (n) % (n) % (n)
Baseline 85.1 (7112) 13.6(1137) 1.3 (107) - 100 (8356)
1st Follow-up 75.8 (659) 13.0 (113) 6.6 (57) 4.6 (40) 100 (869)
2nd Follow-up 79.9 (143) 3.4 (6) 13.4 (24) 3.3 (6) 100 (179)
3rd Follow-up 85.7 (24) 3.6 (1) 0.0 (0) 10.7 (3) 100 (28)
Treatment
overall   2.2 (188)  100 (8356)
doi: 10.1371/journal.pone.0079427.t004
state-of-the-art software sonograms were captured and
transmitted to experts located in Switzerland. Using this
telemedicine, diagnoses could be validated and treatment
recommendations discussed on a daily base.
The following limitations have to be addressed: Loss to
follow-up in our study was high compared to European studies.
However, our study included several thousand participating
families in a vast country and journeys to the hospital were
exhausting for parents and patients. Unfortunately, we do not
know how the hips of those lost to follow-up evolved. There
were some protocol violations: some examinations took place
later than recommended in the SVUPP guidelines and a small
proportion of procedures carried out did not conform to SVUPP
recommendations.
The DDH incidence identified in our study in Mongolia is
comparable to incidence rates reported in unselected newborn
populations in Europe who were also examined within the first
few days of delivery [2-4]. With the exception of multiple births
the risk factors identified in our study were similar to the risk
factors reported in the literature [2-4,6]. The quality of treatment
and treatment outcomes were comparable to those reported for
children in resource-rich countries [10]. A recent study in
Turkey observed worsening of Type 2a hips and therefore
recommends a close follow-up for patients with an initial Type
2a diagnosis [11]. This recommendation is supported by the
findings from our study: We found that 25 initially controlled
Type 2a hips evolved into Type 2c-3 hips at first follow-up. As
in the study reported from Turkey [11] all of these hips
recovered with adequate treatment until second follow-up. In
our birth cohort all patients with a 2c to 4 type hip have been
treated and therefore we cannot assess whether or not these











follow-up exam mean +/- SD 41 +/- 28 37 +/- 16 33 +/- 6
 median 33 33 31
 interquartilerange 30-41 29-35 29-35
 range 11-290 23-110 28-53
baseline - 2nd
follow-up exam mean +/- SD 72 +/- 33   
 median 64   
 interquartilerange 58-74   
 range 32-359   
baseline - 3rd
follow-up exam mean +/- SD 112 +/- 45   
 median 95   
 interquartilerange 81-126   
 range 59-224   
Abbreviation: SD, standard deviation.
doi: 10.1371/journal.pone.0079427.t005
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hips would have resolved spontaneously. Moreover, our study
does not include controls not receiving treatment to allow such
an assessment.
Whether, how and when to screen for DDH in newborns is
still a matter of debate. Some authors argue that the benefit is
unclear because neonatal DDH can spontaneously resolve and
the effects of long term outcomes in adulthood have not been
established. Others claim that only a selected sub-cohort of all
newborns should be evaluated with ultrasound [10,12-15].
Clarke et al. could confirm that selective ultrasound is a
successful surveillance strategy and has economic advantages
compared to comprehensive screening [15]. However, the
results and recommendations generated in European and
North American studies cannot be transferred to Mongolia.
Europe is mainly using the Graf technique, however, America
the Harcke technique, which makes results difficult to compare.
In Mongolia the currently provided standard care to diagnose
and treat DDH is unreliable and potentially harmful, both in
terms of exposure to radiation and treatment complications.
Diagnosis of DDH is based on a clinical examination for
asymmetric gluteal folds and the Ortolani test. However,
neither are reliable tests of hip abnormalities [16,17]. Patients
with positive test results receive plain film radiography at
follow-up visits. Unfortunately, the x-ray equipment is often
outdated and projection errors are not always accounted for. In
Mongolia most children are at least 6 months old when they are
diagnosed with DDH. Standard care consists of overhead
extensions for repositioning, and Pavlik harnesses with a
forced abduction of up to 90 degrees, which can cause
avascular necrosis of the femoral head. Moreover, if a child
needs hip surgery, standards are usually not sufficient to allow
complex interventions in infants and toddlers in Mongolia.
The earliest possible diagnosis of DDH in newborns allows
early and effective treatment. Hips are still highly potent in
ossification within the first three months of life [5]. From
research in Western Europe, we know that dynamic
examination after Graf for early detection which also includes a
stress test in borderline cases, and treatment of hip
abnormalities in newborns reduces the incidence of undetected
DDH later on in life which would require open reduction [18]. In
Norway, it has been estimated that 9% of all primary hip
replacements are caused by DDH [19].Our study’s successful
treatment and follow-up strategy is supported by a recent
publication by Tschauner et al. that concluded that “ultrasound
screening based-treatment of decentered hip joints has
become safer, shorter and simpler: ‘‘safer’’ means lower rate of
avascular necrosis, ‘‘shorter’’ means less treatment time due to
earlier onset and ‘‘simpler’’ means that the devices are now
less invasive and highly standardized” [20].
In terms of sustainability and capacity building our project
may serve as a role model for the development of newborn
screening programs in the Asia Pacific region [21]. An initial
training phase was provided by pediatricians from Switzerland.
Training of physicians in other hospitals in other regions of the
country is now led by Mongolian pediatricians. Swiss experts
will be available as advisors and continue to visit the country
every year.
In a nested case-control design, we will evaluate the role of
swaddling on the unsteady development of Type 2a hips which
led to treatment initiation during follow-up. This is topical and
important, especially in Mongolia where swaddling is common
(Figure 5). We will continue to monitor the patients enrolled in
our cohort over the next years and collect information on hip
development. This will lay the ground for a study on outcomes
later in the lives of our participants. We will establish outpatient
clinics to facilitate participation for families who live in rural
provinces far from Ulaanbaatar. With the expansion of the
study to other hospitals and regions of the country, we aim to
demonstrate that a population-based ultrasound screening
program for DDH in children is feasible and can improve the
health of Mongolians.
Conclusion
This study suggests that the incidence of DDH in Mongolian
neonates is comparable to that in Europe. Early ultrasound-
based assessment and splinting treatment of DDH led to
mature hips in all children followed up. Procedures are feasible
and will be continued.
Figure 5.  Traditional swaddling in Mongolia.  The legal guardian of the subject in the photograph has given written informed
consent, as outlined in the PLoS consent form, to publication of their photograph.
doi: 10.1371/journal.pone.0079427.g005
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Supporting Information
Figure S1.  Development of type 3 hips on person level.
(DOCX)
Figure S2.  Development of type 4 hips on person level.
(DOCX)
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